A multicenter study of recombinant factor VIII (Recombinate): safety, efficacy and inhibitor risk in previously untreated patients with hemophilia A - Bray, G L; Gomperts, E D; Courier, S; Gruppo, R; Gordon, E M; Manco-Johnson, M; Shapiro, A; Scheibel, E; White, G, III; Lee, M; and the Recombinate Study Group (Blood, 1994)